Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

The win allows Southern (10-13, 8-2 SWAC) to stay within two games of conference leader Texas Southern, which is unbeaten in ...

Good afternoon, and welcome to Varex Imaging Corporation's earnings conference call for the first quarter of fiscal year 2025. With me today are Sunny Sanyal, our President and CEO; and Sam Maheshwari ...

Welcome to the Fortinet fourth quarter 2024 earnings announcement conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a ...

Varonis Systems (NASDAQ:VRNS) reported its financial results for the fourth quarter of 2024, showcasing a modest revenue increase of 3% year-over-year to $158.5 million. Despite surpassing earnings ...